Retroperitoneal lymph node dissection for residual masses after chemotherapyin nonseminomatous germ cell testicular tumor

World Journal of Surgical Oncology

Volumn 8, Issue , 2010, Pages

  Luz, Murilo A ^a   Kotb, Ahmed F ^a   Aldousari, Saad ^a   Brimo, Fadi ^a   Tanguay, Simon ^a   Kassouf, Wassim ^a   Aprikian, Armen G ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; FIBROSIS; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; NECROSIS; NON SEMINOMATOUS GERMINOMA; POSTOPERATIVE COMPLICATION; RETROPERITONEAL CANCER; TERATOMA; TESTIS TUMOR; TUMOR RECURRENCE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; FOLLOW UP; LYMPH NODE METASTASIS; LYMPHADENECTOMY; METASTASIS; METHODOLOGY; MIDDLE AGED; NEOPLASM; NONSEMINOMATOUS GERM CELL TUMOR; RETROPERITONEUM; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; DIAGNOSIS, DIFFERENTIAL; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; RETROPERITONEAL SPACE; RETROSPECTIVE STUDIES; TESTICULAR NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78049490585     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-8-97     Document Type: Article

References (20)

1. Ellison LF, Wilkins K. Cancer prevalence in the Canadian population. Health Rep 2009, 20:7-19.
2. Stenning SP, Parkinson MC, Fisher C, Mead GM, Cook PA, Fossa SD, Horwich A, Jones WG, Newlands ES, Oliver RT, Stenwig AE, Wilkinson PM. Postchemotherapy residual masses in germ cell tumor patients: content, clinical features, and prognosis. Medical Research Council Testicular Tumor Working Party. Cancer 1998, 83:1409-1419. 10.1002/(SICI)1097-0142(19981001)83:7<1409::AID-CNCR19>3.3.CO;2-1, 9762943.
3. Schmoll HJ, Souchon R, Krege S, Albers P, Beyer J, Kollmannsberger C, Fossa SD, Skakkebaek NE, de Wit R, Fizazi K, Droz JP, Pizzocaro G, Daugaard G, de Mulder PH, Horwich A, Oliver T, Huddart R, Rosti G, Paz Ares L, Pont O, Hartmann JT, Aass N, Algaba F, Bamberg M, Bodrogi I, Bokemeyer C, Classen J, Clemm S, Culine S, de Wit M, Derigs HG, Dieckmann KP, Flasshove M, Garcia del Muro X, Gerl A, Germa-Lluch JR, Hartmann M, Heidenreich A, Hoeltl W, Joffe J, Jones W, Kaiser G, Klepp O, Kliesch S, Kisbenedek L, Koehrmann KU, Kuczyk M, Laguna MP, Leiva O, Loy V, Mason MD, Mead GM, Mueller RP, Nicolai N, Oosterhof GO, Pottek T, Rick O, Schmidberger H, Sedlmayer F, Siegert W, Studer U, Tjulandin S, von der Maase H, Walz P, Weinknecht S, Weissbach L, Winter E, Wittekind C, . European Germ Cell Cancer Consensus Group European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 2004, 15:1377-1399. 10.1093/annonc/mdh301, 15319245, European Germ Cell Cancer Consensus Group.
4. Beck SD, Foster RS, Bihrle R, Donohue JP, Einhorn LH. Is full bilateral retroperitoneal lymph node dissection always necessary for post-chemotherapy residual tumor?. Cancer 2007, 110:1235-1240. 10.1002/cncr.22898, 17665498.
5. Vergouwe Y, Vergouwe Y, Steyerberg EW, de Wit R, Roberts JT, Keizer HJ, Collette L, Stenning SP, Habbema JD. External validity of a prediction rule for residual mass histology in testicular cancer: an evaluation for good prognosis patients. Br J Cancer 2003, 88:843-847. 10.1038/sj.bjc.6600759, 2377085, 12644820.
6. Aprikian AG, Herr HW, Bajorin DF, Bosl GJ. Resection of Postchemotherapy Residual Masses and Limited Retroperitoneal Lymphadenectomy in Patients with Metastatic Testicular Nonseminomatous Germ Cell Tumors. Cancer 1994, 74:1329-1334. 10.1002/1097-0142(19940815)74:4<1329::AID-CNCR2820740424>3.0.CO;2-L, 8055456.
7. Hartmann JT, Candelaria M, Kuczyk MA, Schmoll HJ, Bokemeyer C. Comparison of histological results from the resection of residual masses at different sites after chemotherapy for metastatic non-seminomatous germ cell tumors. Eur J Cancer 1997, 33:843-847. 10.1016/S0959-8049(96)00517-5, 9291803.
8. Dindo D, Demartines N, Clavien PA. Classification of Surgical Complications. A New Proposal with Evaluation in a Cohort of 6336 Patients and Results of a Survey. Ann Surg 2004, 240:205-213. 10.1097/01.sla.0000133083.54934.ae, 1360123, 15273542.
9. Hendry WF, Norman AR, Dearnaley DP, Fischer C, Nicholls J, Huddart RA, Horwich A. Metastatic nonseminomatous germ cell tumors of the testis: results of elective and salvage surgery for patients with residual retroperitoneal masses. Cancer 2002, 94:1668-76. 10.1002/cncr.10440, 11920527.
10. Sheinfeld J, Herr HW. Role of surgery in management of germ cell tumor. Semin Oncol 1998, 25:203-209.
11. Foster RS, Donohue JP. Can retroperitoneal lymphadenectomy be omitted in some patients after chemotherapy?. Urol Clin North Am 1998, 25:479-484. 10.1016/S0094-0143(05)70037-9, 9728217.
12. Spermon JR, De Geus-Oei LF, Kiemeney LALM, Witjes JA, Oyen WJG. The role of 18-fluoro-2-deoxyglucose positron emission tomography in initial staging and re-staging after chemotherapy for testicular germ cell tumors. BJU Int 2002, 89:549-556. 10.1046/j.1464-410X.2002.02641.x, 11942962.
13. Baniel J, Foster RS, Rowland RG, Bihrle R, Donohue JP. Complications of Post-Chemotherapy Retroperitoneal Lymph Dissection. J Urol 1995, 153:976-980. 10.1016/S0022-5347(01)67616-X, 7853586.
14. Subramanian VS, Nguyen CT, Stephenson AJ, Klein EA. Complications of open primary and post-chemotherapy retroperitoneal lymph node dissection for testicular cancer. Urol Onc 2009,
15. Williams SB, McDermott DW, Dock W, Bahnson E, Berry AM, Steele GS, Richie JP. Retroperitoneal Lymph Node Dissection in Patients with High Risk Testicular Cancer. J Urol 2009, 181:2097-2102. 10.1016/j.juro.2009.01.026, 19286227.
16. Baniel J, Leibovitch I, Foster RS, Rowland RG, Bihrle R, Donohue JP. Hyperamylasemia after Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Testis Cancer. J Urol 1995, 154:1373-1375. 10.1016/S0022-5347(01)66868-X, 7544838.
17. Beck SDW, Foster RS, Bihrle R, Koch MO, Wahle GR, Donohue JP. Aortic Replacement during Post-Chemotherapy Retroperitoneal Lymph Node Dissection. J Urol 2001, 165:1517-1520. 10.1016/S0022-5347(05)66340-9, 11342909.
18. Coogan CL, Hejase MJ, Wahle GR, Foster RS, Rowland RG, Bihrle R, Donohue JP. Nerve Sparing Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Advanced Testicular Cancer. J Urol 1996, 156:1656-1658. 10.1016/S0022-5347(01)65476-4, 8863564.
19. Winter C, Raman JD, Sheinfeld J, Albers P. Retroperitoneal lymph node dissection after chemotherapy. BJU Int 2009, 104:1404-1412. 10.1111/j.1464-410X.2009.08867.x, 19840021.
20. Eastham JA. Do high-volume hospitals and surgeons provide better care in urologic oncology?. Urol Oncol 2009, 27:417-421.